Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection
Indian J Ophthalmol
;
2018 May; 66(5): 697-699
Artículo
| IMSEAR
| ID: sea-196712
ABSTRACT
Botulinum toxin A (BTA) injections into lacrimal gland are being used for refractory epiphora due to intractable lacrimal disorders with success rates reported from 18% to 86%. Most common side effects are transient ptosis and diplopia. We report a case of a 59-year-old female injected with 2.5 units of BTA injection in each lacrimal gland for functional epiphora. The patient had a history of herpes simplex viral keratitis that was quiescent for more than 2 years. After 3 weeks, she developed reactivation of viral keratitis bilaterally, which was successfully managed with antivirals and topical steroids. Reactivation of quiescent herpes simplex keratitis is a possibility after lacrimal gland BTA and caution should be exercised in such cases.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Revista:
Indian J Ophthalmol
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS